Justin Zhang, Ph.D.
Justin focuses on venture opportunities in the healthcare sector, including biopharma, digital health and healthcare IT, technology-enabled healthcare services, medical devices, and diagnostics. Prior to Norwest, Justin worked at a biotech startup where he worked in corporate strategy and business development roles responsible for platform collaboration deals and asset level out-licensing opportunities. Before that, he […]
John McNeil
John focuses on venture opportunities in the healthcare sector, including digital health and healthcare IT, technology-enabled healthcare services, medical devices, diagnostics, and biopharma. Prior to Norwest, John spent three years at ClearView Healthcare Partners, a boutique strategy consulting firm that works primarily with life sciences clients. While at ClearView, he advised biotech, medtech, and pharma […]
Brian Matesic, MD
Brian is an experienced life sciences investor who focuses on early to mid-stage companies. Prior to joining Norwest, Brian worked at Blackstone Life Sciences, where he helped lead over $1.5B of investments across biotech, medical devices, and diagnostics. He was a Board Observer or Alliance Committee Member at 5 companies, working closely with management teams […]
Ehi Akhirome, MD, PhD
Ehi focuses on venture opportunities in the healthcare sector, including therapeutics, medical devices, diagnostics, digital health and health tech IT and services. Ehi was previously at McKinsey & Company’s Life Sciences practice, where he advised clients in the pharmaceutical and medical products industries on corporate strategy, M&A and R&D. Ehi has an MD and a […]
Tiba Aynechi, PhD
Tiba joins Norwest as a biotech investor with 20+ years of research and investment experience. She invests in healthcare with a focus on early to mid-stage companies within the therapeutics sector. Prior to joining Norwest, Tiba spent over ten years at Novo Holdings A/S, one of the top life sciences investment firms, with offices in […]
